# Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy

> **NCT06089967** · — · COMPLETED · sponsor: **Duke University** · enrollment: 30 (actual)

## Conditions studied

- Cancer
- Immune-related Adverse Event

## Interventions

- **OTHER:** Medical chart review

## Key facts

- **NCT ID:** NCT06089967
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-05
- **Primary completion:** 2024-12-06
- **Final completion:** 2024-12-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06089967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06089967, "Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06089967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*